Synlogic_Logo_Blue.png
Synlogic To Present Three Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
March 07, 2023 06:57 ET | Synlogic, Inc.
– Podium presentation on Phase 2 phenylketonuria (PKU) data – – Poster presentations on Phase 1 homocystinuria (HCU) data and HCU preclinical data – CAMBRIDGE, Mass., March 07, 2023 (GLOBE...
TIP_link_300x300.jpg
Enzymatic DNA Synthesis Market Worth $2.24 Billion, by 2028 with 45.1% CAGR – Global Report by The Insight Partners
February 28, 2023 08:28 ET | The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Enzymatic DNA Synthesis Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global...
LanzaTech Logo.png
LanzaTech and Tadweer to explore collaboration on conversion of waste to alternative fuels
February 16, 2023 08:30 ET | LanzaTech Inc.
ABU DHABI, United Arab Emirates, Feb. 16, 2023 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. ("LanzaTech"), an innovative Carbon Capture and Transformation ("CCT") company that transforms waste carbon...
Global Synthetic Biology Market
Synthetic Biology Global Market Report 2023: Diverse Applications of Synthetic Biology Bolsters Adoption
February 15, 2023 06:08 ET | Research and Markets
Dublin, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market?by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue...
large-molecule-drug-substance-cdmo-market-share.jpg
Global Large Molecule Drug Substance CDMO Market Report 2022: Growing Cardiovascular Diseases (CVD) And CVD-Induced Deaths Bolsters Demand
January 31, 2023 10:58 ET | Research and Markets
Dublin, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Large Molecule Drug Substance CDMO Market Size, Share & Industry Trends Analysis Report By Application (Mammalian, Microbial and Others), By...
Synlogic_Logo_Blue.png
Synlogic Announces Participation in Upcoming Investor and Industry Conferences
January 24, 2023 06:57 ET | Synlogic, Inc.
CAMBRIDGE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced it will participate in the...
MaximizeMarketResearch
Synthetic Biology Market to record rapid growth with a CAGR of 25.4% during the forecast period, Technological Advancements and Growth Opportunities
January 23, 2023 08:23 ET | MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Maximize Market research, a healthcare business research firm has published a report on the “Synthetic Biology Market”. The market report is a combination of...
primarylogo.jpg
Pulmobiotics Highlights Nature Biotechnology Publication of Preclinical Data Demonstrating Clearance of Antibiotic-resistant Lung Infection
January 19, 2023 11:39 ET | Pulmobiotics, S.L.
-- First ‘living medicine’ to treat antibiotic-resistant Pseudomonas aeruginosa infections in the lung, a leading cause of mortality in hospital settings – -- Data demonstrate treatment reduced lung...
Synlogic_Logo_Blue.png
Synlogic Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria (PKU)
January 19, 2023 06:58 ET | Synlogic, Inc.
CAMBRIDGE, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that SYNB1934 was granted...
TelesisBio_Logo_RGB.png
Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results
January 09, 2023 09:00 ET | Telesis Bio
-- Record revenue of $9M in 4QFY22; Increase of 191% over 4QFY21 -- BioXp® Revenue increased by 131% to $3M, in 4QFY22 over 4QFY21 -- Successful achievement of first technical milestone with Pfizer...